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Background: There has been an increasing trend in the incidence of stroke worldwide in recent years, and the
number of studies focusing on the risk factors for stroke has also increased every year. To comprehensively evaluate
the risk factors of stroke identified in prospective Western and Asian cohort studies.
Methods: Population-based cohort studies on stroke were searched in databases (PubMed, EMBASE, Web of Science,
Google Scholar, etc.), and the library of the Third Military Medical University was manually searched for relevant
information. A meta-analysis of Western and Asian studies on risk factors was performed. The pooled hazard ratios
(HRs) with 95% confidence intervals (CIs) were calculated to assess the final group of cohort studies.
Results: After screening, 22 prospective cohort studies were included in the analyses of this investigation. Two
factors, smoking and alcohol consumption, showed statistically significant differences between Western and Asian
populations, and the results were as follows (W/A): 2.05 (95% CI, 1.68 ~ 2.49)/1.27 (95% CI, 1.04 ~ 1.55) and 0.89
(95% CI, 0.76 ~ 1.04)/1.28 (95% CI, 1.07 ~ 1.53). The factor BMI = 18.5-21.9 kg/m2 showed statistically significant
differences only in Western populations, 0.96 (95% CI, 0.93 ~ 0.99); the factor SBP = 120-139 mm Hg showed
statistically significant differences only in Asian populations, 2.29 (95% CI, 1.04 ~ 5.09).
Conclusions: The prevalences of risk factors affect the stroke morbidity in Western and Asian populations, which may
be biased by race. The meta-analysis of population-based studies suggests that different preventive measures should
be adopted for Western and Asian population groups that are at high risk for stroke.
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Stroke is not only the second leading cause of death
worldwide but also one of the main causes of adult-
acquired disabilities [1,2]. In certain countries, the incidence
of stroke has increased over time. For example, the
incidence of stroke in the city of Frederiksberg in
Denmark increased from 618/100,000 during the
period from 1972–1974 to 1,190 per 100,000 during
the period from 1989–1990 [3], and the incidence of
stroke among males in Gothenburg, Sweden increased by
35% per year from 1985 to 1990 [4]. In recent years, the* Correspondence: yd_house@hotmail.com
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unless otherwise stated.incidence of stroke has gradually increased among
younger populations. In a region of Western Norway,
the incidence of ischemic stroke among young adults
was 11.4/100,000 between 1988 and 1997, with
women accounting for the majority of patients who
experienced a stroke before reaching 30 years of age
and males accounting for the majority of patients
who experienced a stroke after 30 years of age [5]. In
India, the prevalence of stroke is 1.54, with a death
rate of 0.6 per 1,000 population; the age-adjusted
stroke mortality is believed to be 60% higher in South-East
Asia than in European populations [6]. The same
situation exists in Iran; a systematic review reported
that the stroke prevalence for various ages in Iran
ranges from 23 to 103 per 100,000 populations [7].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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regarding the risk factors for stroke, which include not only
unhealthy lifestyle habits such as smoking and drinking
but also hypertension, diabetes, and a family history of
diseases, among other traits [8-18]. However, different sets
of risk factors and risk intensities have been identified
by various studies, and no comprehensive systematic
review has compiled and summarized the findings of
these studies. In this investigation, based on a large
number of prospective cohort studies from around the
world, a systematic review and a meta-analysis were
conducted to summarize the risk factors for stroke in
Western and Asian populations.
Methods
Our investigation was conducted as suggested by the
Meta-analysis of Observational Studies in Epidemiology
(MOOSE) group [19]. A detailed query strategy and
inclusion and exclusion criteria were developed, and the
relevant literature was screened for inclusion using these
standards. Two research groups were established. The first
research group was responsible for searching for and
reviewing relevant studies and extracting the original data
from these investigations. The second group evaluated the
quality of the included studies. Finally, pooled statistics
describing various effects were calculated.
Systematic literature search
The following electronic literature databases were
searched: PubMed, EMBASE (the Excerpta Medica
Database), Web of Science, Google Scholar, the Chinese
Biomedical Literature Database (CBM), the integrated
Chinese Medical Citation Index/Chinese Medical Current
Contents (CMCI/CMCC) database, and the Cochrane
Central Register of Controlled Trials (CENTRAL)
database of the Cochrane Library. The following search
terms were utilized: ((((((((stroke) OR ischemic) OR
hemorrhagic) OR observational study) OR cohort study)
AND risk factors) OR incidence) OR mortality) AND
prospective study. In addition, the library of the Third
Military Medical University was manually searched
for relevant information. The period specified in these
searches ranged from the creation date of each database
to May 2013.
Inclusion and exclusion criteria
Studies were included if they met the following criteria:
① The included studies were prospective, population-based
cohort studies; ② The included studies involved research
participants who were volunteers from a community or
hospital, with no limitations placed on sex, age, or type of
stroke, although the participants were required to be free
from any complicating infectious or traumatic conditions;
③ The included studies were required to provide HRs forthe risk factors; ④ The observation endpoint of the
included studies was the onset of stroke; ⑤ The included
studies were required to base the determination of disease
on internationally adopted professional diagnostic criteria
[20,21]; ⑥ Comparability of the cohorts was required on
the basis of the design or analysis; ⑦ The included studies
were required to provide a full contingency table and/or ad-
justed HR/RR (relative risk) values.
The exclusion criteria included the following: ① Studies
examining populations that might be affected by interac-
tions between genes and the environment, such as the
Asian-American population, were excluded; ② Case
control studies and other retrospective studies were
excluded from consideration; ③ Duplicate publications,
animal experiments, reviews, and systematic reviews were
excluded from consideration.
Selection and data extraction
The retrieved literature was carefully reviewed, and
various information was extracted for each examined
study, including the study’s first author, publication
year, sample size, study type, population characteristics,
study endpoint, and HR/RR values and 95% confidence
intervals (CIs) (or a contingency table). The data were
independently extracted in a blinded manner by two
researchers (LZ and XC) from the first research group. A
third researcher (LL) from this research group was
consulted to resolve discrepancies in the extracted data,
and a consensus was reached through discussion.
Quality assessment and statistical analyses
The included observational studies were subjected to a
comprehensive quality assessment using the Newcastle-
Ottawa Scale as a guide [22]. This quality evaluation
was performed in a blinded manner by two researchers
(YW and YZ) from the second research team, who
assigned quality scores to the included studies. The studies
that were given different quality scores by the two
researchers were referred to a third researcher (DY) from
this research team for evaluation, and a final quality score
was obtained.
Q tests were conducted to determine the heterogeneity
of the included studies. If I2 ≥ 50% and P < 0.1, a
random-effects model was used to combine the studies;
by contrast, if I2 ≤ 50% and P > 0.1, a fixed-effects model
was used to combine the studies. The adjusted HR was
used to measure the effect sizes for the pooled prospective
cohort studies, and 95% CIs were determined for the
pooled studies. Egger’s regression test was used to verify the
absence of publication bias, and by model transformation
between the fixed effects model and random effects
model for the sensitivity analysis. The fundamental
approach utilized in this non-parametric method involves
first trimming (removing) small sample studies that cause
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mainder is then used to estimate the center value of the
funnel plot, and the removed studies and their corre-
sponding estimated missing values are then entered
into the plot on both sides of this center value [23],
enabling an assessment of the stability of the entire
systematic review. All of the statistical analyses were
conducted using the Stata 11.0 software package.
Results
Included studies
The database search resulted in the identification of 1,288
articles; in addition, 2 conference-related publications
were identified from other sources. In total, 224 of these
articles were duplicates that had been identified in
multiple electronic databases, and 941 articles did notFigure 1 Flow diagram.address the desired research topic; thus, 125 studies
were included in the initial screening (including 123
articles and two conference-related publications). The
initial screening of the abstracts of these studies resulted
in the exclusion of 51 non-prospective cohort studies, 15
reviews or systematic reviews, and 2 animal studies. The
full-text versions of the remaining 56 articles were then
assessed, and 34 articles that did not meet the inclusion
criteria were excluded from consideration. Ultimately,
22 prospective cohort studies were included in this
systematic review and meta-analysis (Figure 1 and Table 1).
Study characteristics
This study examined data reported by researchers from
Western (North America, Europe, and Oceania) and Asian
(East Asia, South Asia, and Southeast Asia) countries. In












who had a stroke)
Source of the cohort
A.G. Shaper [11] 1991 Men England Ischemic &
hemorrhagic
7,735 110 Smoking (98) The British Regional Heart Study [24]
Kathryn M. Rexrode [25] 1997 Women England Ischemic &
hemorrhagic
866 672 BMI (672) The Nurses' Health Study [26,27]




12,866 39 SBP (36), Hypertension (17),
Diabetes (3), Smoking (19)
The PROCAM Study△ [29,30]




2,805 306 BMI (306), SBP (306), Diabetes
(N/A), Coronary heart disease
(N/A), AF (N/A), Smoking (N/A)
The Dubbo Study [32]




3,186 2,403 AF (265), Diabetes (634), Ischemic
heart disease (431)
The hospital participants in an
Asian country
P McCarron [34] 2001 Men England Ischemic &
hemorrhagic
4,826 293 BMI (293), SBP (293), Diabetes (13),
AF (9), Smoking (87)
The Caerphilly and Speedwell
Collaborative Studies [35,36]




1,268 45 BMI (45), SBP (45), Hypertension (N/A) The cadre's sanitarium in Xi’an, China






4,440 329 BMI (329), Hypertension (150),
Diabetes (24), Coronary heart disease
(53), AF (32), LVH (45), Alcohol (124),
Smoking (84)
The population-based survey of
atrial fibrillation [39]
Yun-Mi Song (a) [40] 2004 Men Korea Ischemic &
hemorrhagic
234,863 7,444 BMI (7,444), SBP (7,444) The participants were provided
by KNHS.




14,057 10,716 SBP (10,716) The participants were provided
by KNHS.
Xiao-Fei Zhang [42] 2004 Men China Ischemic &
hemorrhagic
5,092 124 BMI (124), SBP (124), Hypertension
(80), Smoking (124)
The workforce of Beijing, China




30,378 565 SBP (565), Smoking (188),
Diabetes (57)
The CMCS study△ [44]
Per Harmsen [45] 2006 Men Sweden Ischemic &
hemorrhagic
7,457 317 BMI (317), SBP (317), Diabetes
(147), AF (37), Smoking (159)
The Multifactor Primary Prevention
Study [46]
Mohsen Janghorbani [47] 2007 Women Iran Ischemic &
hemorrhagic
121,701 2,384 Diabetes (92) The Nurses’ Health Study [26,27]




9,651 226 BMI (226), Hypertension (80),
Smoking (108), Alcohol (61)
The participants of the Miyako
Study [49,50]
Cornelia Weikert [51] 2007 Men &
women
Germany Ischemic 25,538 85 Hypertension (74), Diabetes (14),
Alcohol (27)
The European Prospective
Investigation into Cancer and
Nutrition [52]




56,510 78 Diabetes (33), Alcohol (24),
Smoking (38)
Community residents of Shanghai,
China
Michiaki Kubo [54] 2008 Men &
women
Japan Ischemic 6390 430 Hypertension (N/A), Diabetes (N/A),
Smoking (N/A), Alcohol (N/A)




















Table 1 Characteristics of the prospective studies on stroke (Continued)




4549 306 SBP (306), Hypertension (170),
Diabetes (211), Alcohol (153),
Smoking (221)
The Strong Heart Study [57-59]




1842 427 SBP (427), Diabetes (110), Coronary
heart disease (131), AF (64), LVH (26),
Smoking (89)
The REGARDS study [61]△




71762 2,119 BMI (2119) The Japan Public Health
Center-based prospective
(JPHC) Study




240,000 988 Hypertension (304), Diabetes (145), AF
(161), Smoking (362), Alcohol (260)
The COST cohort [64,65]△
CT: Computed tomography; MRI: Magnetic Resonance Imaging; N/A, no data available; ◆China, India, Indonesia, Korea, Malaysia, the Philippines, Taiwan, Thailand, Singapore, and Vietnam; △PROCAM the Prospective
Cardiovascular Muenster Study; CMCS the Chinese Muhi Provincial Cohort Study; REGARDS, the Reasons for Geographic and Racial Differences in Stroke; COST, the Copenhagen Stroke Study. KNHS, Korean National
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http://www.biomedcentral.com/1471-2458/14/776the 22 prospective cohort studies that were included in this
investigation, the sample sizes ranged from a minimum of
39 cases to a maximum of 7,444 cases; 30,406 cases were
examined in these studies. Eleven of the included studies
involved Western populations, and the remaining 11
studies involved Asian populations. In 20 of the included
studies, the outcomes included both ischemic stroke and
hemorrhagic stroke, whereas the remaining 2 studies only
examined ischemic stroke (Table 1).
Synthesis of results
This study examined 7 risk factors for stroke in human
populations, including biochemical indices, lifestyle choices,
and medical history. A meta-analysis produced pooled HRs
with 95% CI values for each of these factors.
The combined results indicated that 6 factors affected
the incidence of stroke in Western populations. These
factors included BMI, SBP, hypertension, diabetes, cardiac
causes, and smoking. The following pooled HR values
with 95% CIs were obtained for these factors: 0.96
(0.93 ~ 0.99) for a BMI of 18.5-21.9 kg/m2; 2.39 (1.44 ~ 3.97)
for an SBP ≥140 mm Hg; 1.79 (1.39-2.30) for hypertension;
1.85 (1.43 ~ 2.38) for diabetes; 1.74 (1.47 ~ 2.04) for cardiac
causes; and 2.05 (1.68 ~ 2.49) for smoking; However, 0.89
(0.76 ~ 1.04) for alcohol consumption (Table 2 and
Additional files 1, 2, 3, 4, 5, 6, 7, 8).
In addition, in a subgroup analysis of smoking and
cardiac causes, there was statistical significance in the 4
subgroups, including atrial fibrillation, current smoking,
smoking ≤20 cigarettes/d and smoking >20 cigarettes/d.
The pooled HRs with 95% CI values were as follows:
1.59 (1.33 ~ 1.90), 2.27 (1.76 ~ 2.93), 2.31 (1.80 ~ 2.96)
and 2.99 (2.31 ~ 3.86) (Table 2 and Additional files 5, 7).
The included studies of Asian populations indicated that
7 factors affected the incidence of stroke. These factors
included BMI, SBP, hypertension, diabetes, cardiac causes,
smoking and alcohol. The following pooled HR values
with 95% CIs were obtained for these factors: 1.28 (1.15 ~
1.46) for a BMI of ≥25.0 kg/m2; 2.29 (1.04 ~ 5.09) for an
SBP of 120–139 mm Hg; 6.22 (2.27 ~ 17.08) for an
SBP ≥140 mm Hg; 2.84 (2.10-3.82) for hypertension;
1.95 (1.42 ~ 2.67) for diabetes; 1.87 (1.45 ~ 2.42) for
cardiac causes; 1.27 (1.04 ~ 1.55) for smoking; and 1.28
(1.07 ~ 1.53) for alcohol consumption (Table 2 and
Additional files 9, 10, 11, 12, 13, 14, 15, 16).
In the subgroup analysis of cardiac causes, there was
statistical significance for atrial fibrillation. The pooled
HR with the 95% CI was 2.30 (1.50 ~ 3.53) (Table 2 and
Additional file 12).
Quality of the included studies
The Newcastle-Ottawa scale results revealed that 95.45%
of the included studies earned above 2 stars for the
NOS selection item, 77.27% of the included studiesearned above 1 star for the NOS comparability item,
and 36.36% of the included studies earned above 2
stars for the NOS exposure item (Table 3).
Egger's test was performed to assess the influential
factors for each of the two populations that were
examined (Table 4). Publication bias affected 2 factors in
studies of Western populations: cardiac causes (t = 6.32,
P = 0.000) and smoking (t = 6.21, P = 0.000). This analysis
revealed that publication bias affected 4 factors in the
studies of Asian populations: BMI = 22.0-24.9 kg/m2
(t = −9.52, P = 0.000), BMI ≥25.0 kg/m2 (t = 3.36, P = 0.012),
diabetes (t = 4.50, P = 0.003), smoking (t = 11.39, P = 0.000)
and alcohol (t = 1.06, P = 0.008).
By model transformation between the fixed effects
model and random effects model for the sensitivity
analyses of the included factors (Table 4). The sensitivity
analysis results were consistent (Additional files 1, 2, 3, 4,
5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16).
Discussion
This systematic review of prospective cohort studies on
the incidence of stroke summarized 7 risk factors for
stroke that have been reported with relatively high
frequency in prior studies. The prospective cohort studies
incorporated into this review examined 867,782 Western
or Asian participants and included investigations of
large cohorts and studies of small community groups.
To avoid biases attributable to differences in ethnicity
and geography, the statistical analyses of the final
combined results were stratified by Western or Asian
population types.
Six factors affected the incidence of stroke in both
Western and Asian populations. These factors included
hypertension and diabetes, which are well-known risk
factors for the incidence of stroke; thus, these findings
are consistent with the results of earlier reports [66].
Studies have reported that a BMI ≥25 kg/m2 is associated
with increased mortality among middle-aged populations,
particularly from cardiovascular and cerebrovascular
diseases, which are the leading causes of death [67].
Previous studies have reported similar findings for
obesity [68]; in our study, obesity was one of the risk
factors for the onset of disease in Asian populations,
and an elevated BMI was associated with greater risk
(Figure 2). In addition, the result of the risks associated with
a BMI ≥25 kg/m2 was greater among Asian populations
than among Western populations.
Stroke-related studies in the community of Framingham
in the United States and the North Karelia region of
Finland, as well as investigations of interventions for
stroke-related risk factors in 7 Chinese cities, have con-
firmed the existence of a correlation between blood
pressure and stroke [69-74]. SBP, a direct indicator of
hypertension, is also a factor that directly influences
Table 2 Meta-analysis outcomes





















22.0-24.9 1.000 Ref. Group 1.000 Ref. Group
18. 5–21. 9 3F 447**/1,917 0.96(1) 0.93 ~ 0.99(1) 0.010* 5R 1,124**/9,985 0.97(9) 0.88 ~ 1.08(9) 0.626
≥25.0 4R 389**/1,917 1.21(1) 0.99 ~ 1.48(1) 0.159 4R 2,233**/9,985 1.28(9) 1.15 ~ 1.46(9) 0.000*
SBP (mm Hg)
<120 1.000 Ref. Group 1.000 Ref. Group
120-139 2F 14**/332 1.28(2) 0.96 ~ 1.70(2) 0.094 2R 81**/689 2.29(10) 1.04 ~ 5.09(10) 0.041*
≥140 2R 22**/332 2.39(2) 1.44 ~ 3.97(2) 0.000* 2R 30**/689 6.22(10) 2.27 ~ 17.08(10) 0.000*
Hypertension
No 1.000 Ref. Group 1.000 Ref. Group
Yes 5R 715/1,747 1.79(3) 1.39 ~ 2.30(3) 0.000* 4R 80**/825 2.84(11) 2.10 ~ 3.82(11) 0.000*
Diabetes
No 1.000 Ref. Group 1.000 Ref. Group
Yes 9R 667**/2,941 1.85(4) 1.43 ~ 2.38(4) 0.000* 5R 816**/5,860 1.95(12) 1.42 ~ 2.67(12) 0.000*
Cardiac causes#
No 1.000 Ref. Group 1.000 Ref. Group
Yes 6R 558**/2,511 1.74(5) 1.47 ~ 2.04(5) 0.000* 1F 431/2,403 1.87(13) 1.45 ~ 2.42(13) 0.000*
Cardiac causes
(Atrial fibrillation)
No 1.000 Ref. Group 1.000 Ref. Group
Yes 3F 96**/1,062 1.59(6) 1.33 ~ 1.90(6) 0.000* 1F 265/2,403 2.30(14) 1.50 ~ 3.53(14) 0.000*
Smoking
No 1.000 Ref. Group 1.000 Ref. Group
Yes△ 10R 960**/3,115 2.05(7) 1.68 ~ 2.49(7) 0.000* 5R 350**/858 1.27(15) 1.04 ~ 1.55(15) 0.020*
Smoking (former) 4R 135**/3,115 1.22(7) 0.94 ~ 1.59(7) 0.135 N/A N/A N/A N/A N/A
Smoking (Current) 5R 274**/3,115 2.27(7) 1.76 ~ 2.93(7) 0.000* N/A N/A N/A N/A N/A
Smoking
(≤20 Cigarettes/d)
3F 42**/3,115 2.31(7) 1.80 ~ 2.96(7) 0.000* N/A N/A N/A N/A N/A
Smoking
(>20 Cigarettes/d)
3F 30**/3,115 2.99(7) 2.31 ~ 3.86(7) 0.000* N/A N/A N/A N/A N/A
Alcohol
No 1.000 Ref. Group 1.000 Ref. Group
Yes△ 4F 537**/1,708 0.89(8) 0.76 ~ 1.04(8) 0.477 3F 85**/734 1.28(16) 1.07 ~ 1.53(16) 0.011*
*P values for comparison between the subjects who had a stroke and those who did not; **Insufficient data #Cardiac causes: Coronary heart disease, Left atrial hypertrophy, Angina, Atrial fibrillation; F: Fixed effects
model, R: Random effects model; N/A, no data available. BMI, Body mass index; SBP, Systolic blood pressure; Smoking/former: smoking cessation; Alcohol: Often drunk, △The statistical significance between Western


























Yao He37 2003 ★★★ ★ ★★
Xiao-Fei Zhang 42 2004 ★★★ ★★ ★★★
Yan Wang53 2007 ★★★ ★ ★
Wei Wang 43 2006 ★★ ★ ★★
Other population
A.G.Shaper11 1991 ★★★ ★★ ★★
Kathryn M.
Rexrode25
1997 ★★★ ★★ ★★
K. Berger28 1998 ★★★ ★★ ★★★
Leon A. Simons 31 1998 ★★★ ★★ ★★
P McCarron34 2001 ★★★★ ★★ ★★★
Cornelia Weikert51 2007 ★★★★ ★★ ★★★
Per Harmsen45 2006 ★★★ ★★ ★★
Ulla Brasch
Mogensen63
2012 ★★★ ★ ★★
Helen Rodgers38 2004 ★★★★ ★★ ★★★
George Howard60 2011 ★★★ ★★ ★★
K.S. Wong33 1999 ★★★★ ★★ ★★
Yun-Mi Song (a)40 2004 ★★★★ ★ ★★★
Yun-Mi Song (b)41 2004 ★★★★ ★ ★★
Mohsen
Janghorbani47
2007 ★★★★ ★★ ★★★
Truong-Minh
Pham48
2007 ★★★ ★★ ★★
Michiaki Kubo54 2008 ★★★ ★★ ★★★
Ying Zhang56 2008 ★★★★ ★★ ★★
Ulla Brasch
Mogensen63
2012 ★★★ ★ ★★
Note [22]: Selection: 1. Representativeness of the exposed cohort. 2. Selection
of the non-exposed cohort. 3. Ascertainment of exposure. 4. Demonstration
that the outcome of interest was not present at the beginning of the study.
(High quality, >2 stars); Comparability: 1. Comparability of the cohorts on
the basis of the design or analysis. (High quality, >1 star); Exposure: 1.
Assessment of the outcome. 2. Was the follow-up long enough for outcomes
to occur? 3. Adequacy of the follow-up of the cohorts. (High quality, >2 stars).
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http://www.biomedcentral.com/1471-2458/14/776the incidence of stroke. However, the risk of stroke was
elevated in hypertensive patients relative to patients exhi-
biting high blood pressure without previously diagnosed
hypertension [75]. The results of this study indicate that
an increasing SBP is associated with an increased risk of
stroke. In fact, the risk of stroke was greater among the
participants with SBP ≥140 mm Hg than among the
patients with diagnosed hypertension in both Asian and
Western populations (Figure 2). A possible reason for this
phenomenon is that most individuals diagnosed with
hypertension have received appropriate anti-hypertensiveinterventions. Previous studies have shown that patients
diagnosed with stroke often receive antihypertensive
medication [15,16]. From the results of our investigation,
the risks associated with SBP ≥140 mm Hg is greater
among Asian populations than among Western popula-
tions. For example, the cohort studies of a workforce in
China [42],which examined steelworkers in Beijing, China,
found an age-adjusted RR of 5.6 among these individuals,
which was higher than the RR of 3.5 obtained in the
Framingham study [76]. In our previous retrospective
study [77], the Rothman and Keller [78] model was
utilized to establish a multivariate model for predicting
the incidence of stroke in human populations. Consistent
with previous reports, this model represented the
occurrence of stroke resulting from the combined
long-term effects of multiple risk factors [79]. Our prior
results also explored the effects of the interactions
between hypertension and other risk factors on the
incidence of stroke. However, the question of whether
changes in other risk factors could alter the intensity of
the risk of hypertension with respect to the incidence of
stroke in a particular population (Western or Asian)
merits additional study and discussion.
The Busselton Study reported that atrial fibrillation is
a risk factor for stroke, with an RR of 5.9 [80], and other
studies have also consistently indicated that atrial
fibrillation is a risk factor for stroke [81]. In our
investigation, atrial fibrillation was again identified as
a risk factor; the result for this factor in Western
populations was 2.30 (1.50 ~ 3.53), and there was no
difference in Asian populations by interval estimation
(Table 2). Consistent with our results, cardiovascular-related
diseases (such as angina and CHD) were identified as
risk factors for stroke as early as the Framingham
Study and related reports [82]. Previous studies have
suggested that left ventricular hypertrophy (LVH) is not
correlated with the occurrence of stroke [13]; however,
our investigation indicated that LVH is a risk factor for
stroke in Western populations. Therefore, effective
measures for preventing stroke in Western populations
include lifestyle improvements, appropriate treatments,
and reductions in the morbidities associated with chronic
cardiovascular and cerebrovascular diseases.
Smoking is a risk factor for stroke, and the HR values
for smoking-related behaviors were relatively high in
Western populations. After stratifying the results based
on the periods during which smoking occurred, it was
determined that former smoking had no effect on the
incidence of stroke in Western populations. Certain
prior studies have suggested that being a former smoker
can affect the incidence of stroke [83-85], whereas other
studies have found no significant effects associated with
this characteristic [86]. We observed a dose–response
association for the number of cigarettes smoked per day
Table 4 Egger's test & Sensitivity analysis













Asian (HR 95% CI)◎
Sensitivity analysis of
Asian (HR 95% CI)◇
BMI (kg/ m2)
22.0-24.9 1 N/A 1 1 1 N/A 1 1
18. 5–21. 9 −1.65 0.240 0.96 (0.93 ~ 0.99)(1) 0.97 (0.86 ~ 1.09)(1) −9.52 0.000* 0.93 (0.90 ~ 0.97)(9) 0.97 (0.88 ~ 1.08)(9)
≥25.0 −0.48 0.652 1.02 (0.99 ~ 1.05)(1) 1.21 (0.99 ~ 1.48)(1) 3.36 0.012* 1.26 (1.22 ~ 1.31)(9) 1.28 (1.15 ~ 1.43)(9)
SBP ( mm H g)
<120 1 1 1 N/A 1 1
120-139 N/A▲ N/A▲ 1.28 (0.96 ~ 1.70)(2) 1.28 (0.95 ~ 1.73)(2) N/A▲ N/A▲ 1.96 (1.42 ~ 2.69)(10) 2.30 (1.03 ~ 5.09)(10)
≥140 N/A▲ N/A▲ 2.25 (1.74 ~ 2.92)(2) 2.39 (1.44 ~ 3.97)(2) N/A▲ N/A▲ 4.69 (3.37 ~ 6.52)(10) 6.22 (2.27 ~ 17.08)(10)
Hypertension
No 1 N/A 1 1 1 N/A 1 1
Yes 1.78 0.173 1.65 (1.43 ~ 1.90)(3) 1.79 (1.39 ~ 2.30)(3) 2.01 0.101 2.66 (2.29 ~ 3.10)(11) 2.84 (2.10 ~ 3.82)(11)
Diabetes
No 1 N/A 1 1 1 N/A 1 1
Yes 1.17 0.280 1.72 (1.52 ~ 1.94)(4) 1.85 (1.43 ~ 2.38)(4) 4.50 0.003* 2.19 (2.01 ~ 2.39)(12) 1.95 (1.42 ~ 2.67)(12)
Cardiac causes#
No 1 N/A 1 1 1 N/A 1 1
Yes 6.32 0.000* 1.62 (1.50 ~ 1.75)(5) 1.74 (1.47 ~ 2.04)(5) N/A▲ N/A▲ 1.87 (1.45 ~ 2.42)(13) 1.86 (1.36 ~ 2.55)(13)
Cardiac causes (Atrial
fibrillation)
No 1 N/A 1 1 1▲ N/A 1 1
Yes 6.02 0.105 1.59 (1.33 ~ 1.90)(6) 1.59 (1.33 ~ 1.90)(6) N/A▲ N/A▲ 2.30 (1.50 ~ 3.53)(14) 2.30 (1.50 ~ 3.53)(14)
Smoking
No 1 N/A 1 1 1 N/A 1 1
Yes 6.21 0.000* 1.97 (1.80 ~ 2.15)(7) 2.05 (1.68 ~ 2.49)(7) 11.39 0.000* 1.29 (1.12 ~ 1.48)(15) 1.27 (1.04 ~ 1.55)(15)
Smoking (Former) 2.09 0.171 1.20 (1.00 ~ 1.43)(7) 1.22 (0.94 ~ 1.59)(7) N/A N/A N/A N/A
Smoking (Current) 2.41 0.053 2.22 (1.96 ~ 2.53)(7) 2.27 (1.76 ~ 2.93)(7) N/A N/A N/A N/A
Smoking (≤20 Cigarettes/d) −0.74 0.536 2.31 (1.80 ~ 2.96)(7) 2.31 (1.80 ~ 2.96)(7) N/A N/A N/A N/A
Smoking (>20 Cigarettes/d) 0.73 0.600 2.99 (2.31 ~ 3.86)(7) 2.97 (2.16 ~ 4.09)(7) N/A N/A N/A N/A
Alcohol
No 1 N/A 1 1▲ 1 N/A 1 1
Yes −1.42 0.16 0.89 (0.76 ~ 1.04)(8) 0.92 (0.74 ~ 1.14)(8) 1.06 0.008* 1.28 (1.07 ~ 1.53)(16) 1.29 (1.07 ~ 1.57)(16)
*P values for publication bias; N/A, no data available; ▲Synthesis of References less than 3; BMI, Body mass index; #Cardiac causes: Coronary heart disease, Left atrial hypertrophy, Angina, Atrial fibrillation; ◎Fixed





























































































Figure 2 Risk factors in Western and Asian populations. (**Former, Current, ≤20 Cigarettes/d and >20 Cigarettes/d; #Cardiac causes:
Coronary heart disease, Left Atrial hypertrophy, Angina, Atrial fibrillation; HR Hazard risk; CI, Confidence interval; BMI, Body mass index; SBP,
Systolic blood pressure).
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smoking more than 20 cigarettes per day was much
greater than the HR values of other risk factors by point
estimation (Figure 2); this result is consistent with the
findings of previous studies [86,87]. Therefore, reducing
daily cigarette consumption is an effective preventive
measure for reducing the incidence of stroke.
The results from the studies of Asian populations indi-
cated that long-term alcohol consumption was also a risk
factor for stroke, although this factor had no effect on the
incidence of stroke in Western populations (Table 3). Prior
studies have also produced controversial results with
respect to the significance of this factor: certain studies have
determined that heavy long-term alcohol consumption is a
risk factor for stroke [88], but other studies have reached
the opposite conclusion [89]. However, heavy long-term
alcohol consumption is a risk factor for many chronic
diseases, and therefore, limiting alcohol consumption may
play an indirect role in preventing the incidence of stroke.
Limitations
This systematic review and meta-analysis used the
Newcastle-Ottawa scale to score all of the included
studies. Overall, the quality of the studies on Chinese
populations was significantly lower than the quality of the
studies on other populations (T-Test: Z = 3.015, P = 0.007).
The primary reason for this finding was that the
populations examined in the former studies were mostly
large, long-term, community-based cohorts. For example,
the studies by the British regional heart study [24] and the
PROCAM study [29,30], among others, were based on
data from large European cohorts [29,30,32]. By contrast,
most of the included Asian studies examined small
community-based cohorts or even hospital cases. Forexample, the research participants assessed by the cadre's
sanitarium of Xi’an, China [37] were recruited from a
sanatorium for retired military cadres in Xi'an, China.
Result biases may be relatively low for large community
cohorts but higher for smaller samples. In addition, bias
may also be related to the dropout rate. For instance, the
study in Shanghai, China [53] reported a dropout rate of
3.09%, whereas the CMCS study [44] reported a dropout
rate of up to 22.5%. Although this investigation involved
the examination of a large number of literature databases,
there was less investigation of the unpublished literature
and conference-related information, potentially creating
publication bias.
Furthermore, only a limited number of studies were
included in this investigation; thus, a large amount of
data regarding risk factors was missing. In addition, few
studies were pooled to obtain certain data points, par-
ticularly for Asian populations, and the number of
studies finally included in the meta-analysis was very
low for individual risk factors (usually in the range of
1 to 10), and this issue might have produced bias in
the results. Therefore, these limitations are related to
the absence of studies from South Asia and West
Asia, and we believe this might be one reason for the
publication bias. Consequently, to obtain more reliable
data and results, additional large-sample, multi-center,
randomized controlled studies and/or long-term cohort
studies must be conducted.
Conclusions
This meta-analysis presents the data from large-scale
prospective cohort studies to summarize and evaluate the
risk factors for stroke in Western and Asian populations.
The results of this investigation are credible, and the
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http://www.biomedcentral.com/1471-2458/14/776pooled results obtained in this review are more reliable
than the findings from prior small-scale cohort studies
and case–control studies. The analyses conducted in this
investigation revealed that Western and Asian populations
differ with respect to the factors that affect the incidence
of stroke. Therefore, different interventional approaches
should be implemented to reduce the risk of stroke among
high-risk individuals from different regions and different
ethnic groups.Additional files
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